Home Clinical Trials LDE225 Recruiting in the UK

Latest News
LDE225 Recruiting in the UK PDF Print E-mail
Tuesday, 15 March 2011 17:01
Dose Finding and Safety of Oral LDE225 in Patients With Advanced Solid Tumors is now recruiting patients in the UK.

This Phase 1 trial is currently available in the UK and recruiting patients.  This is a broad study in solid tumours, medulloblastoma and includes those with advanced BCC that are not surgically eligible. 

Further information about the trial can be accessed here.   If you require further information after viewing the page, please do not hesitate to get in touch via the Contact Us area of this site.

 
Last Updated on Tuesday, 15 March 2011 17:21
 

  Written and produced by Professor P A Farndon, Clinical Geneticist, Jim Costello (deceased) & Margaret Costello, unless otherwise stated.

The Gorlin Syndrome Group is a Registered Charity - No 1096361

© Gorlin Syndrome Group